Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2016 16:30 ET | Source: Cellect Biomed

Cellect Awarded NIS 3.5 Million BIRD Foundation Grant for the Development and Commercialization of Innovative Stem Cell Selection Technology

KFAR SABA, Israel, June 15, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
June 14, 2016 09:02 ET | Source: Cellect Biomed

Cellect to be Included in TASE Indices

KFAR SABA, Israel, June 14, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or “the Company”), a developer of innovative technology which enables the functional selection of...
May 09, 2016 09:21 ET | Source: Cellect Biomed

Cellect Granted Canadian Patent For Its Cell Selection Technology Platform

TEL AVIV, Israel, May 09, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology that enables the functional selection of stem...
April 19, 2016 12:00 ET | Source: Cellect Biomed

Cellect Announces the Signing of a Collaboration Agreement with Accellta

- On the Path to a First License Agreement - TEL AVIV, Israel, April 19, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative...
March 07, 2016 09:00 ET | Source: Cellect Biomed

Cellect Announces Receipt of IRB Approval to Conduct Its Clinical Trial in Leukemia Patients

TEL AVIV, Israel, March 07, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announces today it...
February 16, 2016 09:30 ET | Source: Cellect Biomed

Cellect Announces a NIS 8 Million Private Placement Led by Foreign Investors

TEL-AVIV, Israel, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announced today the...
December 16, 2015 11:30 ET | Source: Cellect Biomed

Cellect Receives Approval to Commence Human Trial in Healthy Volunteers at the Schneider Medical Center

TEL-AVIV, Israel, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
December 09, 2015 10:36 ET | Source: Cellect Biomed

Cellect Announces Positive Results From BMT Safety Test

TEL AVIV, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...
December 02, 2015 11:45 ET | Source: Cellect Biomed

Cellect Biomed to Present at ASH 57th Annual Meeting on December 6

TEL AVIV, Israel, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a company specializing in the development of an innovative technology platform which enables the functional...
November 09, 2015 08:30 ET | Source: Cellect Biomed

Cellect Biomed Announces Key Leadership Changes

TEL-AVIV, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...